Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 4/20 | 0.35 |
| ▸ | CES1 | P23141 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4890754 | 0.84 | CES2 (0.36) | ALDH1A1ALOX15CES2CES1CYP3A4 | |
| SCHEMBL3260995 | 0.84 | ALDH1A1 (0.46) | ALDH1A1ALOX15CES2CES1HPGD | |
| Hydrochloric Acid SCHEMBL4891176 | 0.82 | ALDH1A1 (0.45) | ALDH1A1ALOX15CES2CES1HPGD | |
| Fluoride SCHEMBL4890762 | 0.82 | ALDH1A1 (0.45) | ALDH1A1ALOX15CES2CES1HPGD | |
| SCHEMBL465753 | 0.79 | ALDH1A1 (0.54) | ALDH1A1ALOX15CES2CES1HPGD | |
| SCHEMBL11388609 | 0.76 | ALDH1A1 (0.50) | ALDH1A1ALOX15CES2CES1HPGD | |
| SCHEMBL4667818 | 0.72 | ALDH1A1 (0.50) | ALDH1A1ALOX15CES2CES1HPGD | |
| SCHEMBL2153533 | 0.72 | ALDH1A1 (0.50) | ALDH1A1ALOX15CYP3A4CYP1A2HPGD | |
| SCHEMBL28671195 | 0.72 | CA12 (0.38) | ALDH1A1ALOX15CYP3A4HPGDGAA | |
| SCHEMBL4318041 | 0.71 | ALDH1A1 (0.48) | ALDH1A1ALOX15CES2CES1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7405331-B2 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-07-29 | — | — | US | disclosed |
| US-20060167324-A1 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1500641-A1 | HIGH-PURITY (FLUOROALKYL)BENZENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167324-A1 | High-purity (fluoroalkyl)benzene derivative and process for producing the same | HBB, AFF4, AFF2 | ALDH1A1 669/4885ALOX15 1401/4885CES2 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.